Search

Showing results for: AUTHOR - IJzerman M

Found: 4 results

Simulating progression-free and overall survival for first-line doublet chemotherapy with or without bevacizumab in metastatic colorectal cancer patients based on real-world registry data Pharmacoeconomics - 2020-11 Degeling, K; Wong, HL; Koffijberg, H; Jalali, A; Shapiro, J; Kosmider, S; Wong, R; Lee, B; Burge, M; Tie, J; Yip, D; Nott, L; Khattak, A; Lim, S; Caird, S; Gibbs, P; IJzerman M
Link to Publisher's Version
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer Lung Cancer - 2020-06-26 Cui, W; Franchini, F; Alexander, M; Officer, A; Wong, HL; IJzerman M; Desai, J; Solomon, BJ
Link to Publisher's Version
Health economic models for metastatic colorectal cancer: a methodological review Pharmacoeconomics - 2020-04-22 Degeling, K; Vu, M; Koffijberg, H; Wong, HL; Koopman, M; Gibbs, P; IJzerman M
Link to Publisher's Version
Systematic Review of Efficacy and Health Economic Implications of Real-world Treatment Sequencing in Prostate Cancer: Where Do the Newer Agents Enzalutamide and Abiraterone Fit in? European Urology Focus - 2020-04-06 Pereira-Salgado, A; Kwan, EM; Tran, B; Gibbs, P; De Bono, J; IJzerman M
Link to Publisher's Version

An error has occurred. This application may no longer respond until reloaded. Reload 🗙